Inserm maintains a long tradition of European and international cooperation: every year, over 6,000 cooperative arrangements with foreign partners are reported by its research teams. These arrangements involve all areas of research in life sciences and health. They involve partners from nearly 100 countries. More than half of the cooperative arrangements involve countries in the European Union or its vicinity, but the Institute’s main partner remains the United States, with about 20% of these arrangements.
The extent of Inserm’s international activity reflects an approach simultaneously adopted by:
- the research teams, who initiate and maintain scientific collaborations with their partners,
- Inserm’s Directorate-General, via the signature of partnership agreements and the establishment of specific cooperation schemes: European and International Associated Laboratories (LEA/LIA), European and International Research Groups (GDRE/GDRI), etc.
Inserm also plays an active role within multilateral bodies, including WHO and the UN Global Health Crisis Task Force, as well as several European and international bodies such as the Heads of International Research Organizations (HIROs) and the Coalition for Epidemic Preparedness Innovations (CEPI). The Institute also participates, on behalf of Aviesan, in the governance bodies of the European and Developing Countries Clinical Trials Partnership (EDCTP) and the Innovative Medicine Initiative (IMI).
The Institute is furthermore involved in the theme of climate change and its global health implications.